Skip to main content
. 2022 Nov 1;125:195–208. doi: 10.1016/j.ijid.2022.10.035

Figure 1.

Figure 1

Timing of COVID-19 vaccination and planning of the study enrollment.

Both health care workers and patients with rheumatoid arthritis received three doses of a COVID-19 mRNA vaccine. Blood sampling were performed after 5 weeks (T1) and 6 months (T2) from the first vaccine dose, and after 4-6 weeks from the booster dose (T3).

mRNA, messenger RNA.